Krabbe disease successfully treated via monotherapy of intrathecal gene therapyJOURNAL OF CLINICAL INVESTIGATIONIF13.62020-08-1044OA
Combination intrathecal and intravenous gene therapy reveals a dominant role for treatment age in determining survival and behavioral outcomes in the mouse model of infantile neuronal ceroid lipofuscinosisMOLECULAR GENETICS AND METABOLISMIF3.52020-02-010PREAI
Intrathecal and intravenous combination gene therapy in the mouse model of infantile neuronal ceroid lipofuscinosis extends lifespan and improves behavioral outcomes in moderately affected miceMOLECULAR GENETICS AND METABOLISMIF3.52019-02-010PREAI
Recent progress and considerations for AAV gene therapies targeting the central nervous systemJOURNAL OF NEURODEVELOPMENTAL DISORDERSIF42018-05-18124OAAI
AAV vector comparability across mammalian and insect cell production platforms for treatment of lysosomal diseasesMOLECULAR GENETICS AND METABOLISMIF3.52018-02-010PREAI
Combination dosing of CLN1 gene therapy extends lifespan in a mouse model of infantile neuronal ceroid lipofuscinosisMOLECULAR GENETICS AND METABOLISMIF3.52018-02-014PREAI
The MicroRNA miR-191 Supports T Cell Survival Following Common Chain SignalingJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92016-11-0126OAAI
MicroRNA-23a Curbs Necrosis during Early T Cell Activation by Enforcing Intracellular Reactive Oxygen Species EquilibriumIMMUNITYIF26.32016-03-0152OAAI
MeCP2 enforces Foxp3 expression to promote regulatory T cells' resilience to inflammationPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.12014-06-2350OAAI
MeCP2 Reinforces STAT3 Signaling and the Generation of Effector CD4+ T Cells by Promoting miR-124-Mediated Suppression of SOCS5SCIENCE SIGNALINGIF6.62014-03-1158OAAI
microRNAs at the regulatory frontier: an investigation into how microRNAs impact the development and effector functions of CD4 T cellsIMMUNOLOGIC RESEARCHIF3.12010-12-3032PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项